According to Neurocrine Biosciences 's latest financial reports the company's current earnings (TTM) are $0.33 B. an increase over its 2022 earnings that were of $0.22 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | $0.33 B | 52.44% |
2022 | $0.22 B | 73.74% |
2021 | $0.12 B | -8.82% |
2020 | $0.13 B | 77.78% |
2019 | $78.46 M | 49.83% |
2018 | $52.37 M | -142.57% |
2017 | -$0.13 B | -14.73% |
2016 | -$0.15 B | 53.15% |
2015 | -$94.21 M | 46.25% |
2014 | -$64.42 M | 29.66% |
2013 | -$49.68 M | -3530.8% |
2012 | $1.44 M | -95.73% |
2011 | $33.92 M | |
2009 | -$47.69 M | -45.38% |
2008 | -$87.3 M | -58.87% |
2007 | -$0.22 B | 87.3% |
2006 | -$0.12 B | 351.97% |
2005 | -$25.08 M | -52.09% |
2004 | -$52.34 M | -10.98% |
2003 | -$58.79 M | |
2001 | -$43.89 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Pfizer PFE | $3.26 B | 869.72% | ๐บ๐ธ USA |
AbbVie ABBV | $6.25 B | 1,755.15% | ๐บ๐ธ USA |
Eli Lilly LLY | $6.55 B | 1,845.56% | ๐บ๐ธ USA |
Repligen
RGEN | $66.08 M | -80.38% | ๐บ๐ธ USA |
Athersys ATHX | -$41.77 M | -112.40% | ๐บ๐ธ USA |
ANI Pharmaceuticals ANIP | $19.87 M | -94.10% | ๐บ๐ธ USA |
Palatin Technologies PTN | -$31.58 M | -109.37% | ๐บ๐ธ USA |
Royalty Pharma RPRX | $1.88 B | 460.19% | ๐ฌ๐ง UK |